ALLEGAERT, K.; RAYYAN, M.; COSSEY, V.; VAN GEET, C. Subcutaneous palivizumab (Synagis®) administration in an infant with congenital type 2B von Willebrand disease. Journal of Pediatric and Neonatal Individualized Medicine (JPNIM), Quartu Sant’Elena (CA, Italy), v. 4, n. 1, p. e040104, 2015. DOI: 10.7363/040104. Disponível em: https://jpnim.com/index.php/jpnim/article/view/040104. Acesso em: 17 jul. 2024.